About methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate
methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate (PubChem CID 174367386) has the molecular formula C25H27F2N3O6
and a molecular weight of 503.50 g/mol. Its IUPAC name is methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate.
Molecular Properties
| Compound Name | methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate |
| PubChem CID | 174367386 |
| Molecular Formula | C25H27F2N3O6 |
| Molecular Weight | 503.50 g/mol |
| Exact Mass | 503.19 |
| IUPAC Name | methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate |
| SMILES | CCC1CC(C=O)N(C(N)c2ccc(C(=O)C(=O)OC)cc2)N=C1c1ccc(OC)c(OC(F)F)c1 |
| InChI | InChI=1S/C25H27F2N3O6/c1-4-14-11-18(13-31)30(23(28)16-7-5-15(6-8-16)22(32)24(33)35-3)29-21(14)17-9-10-19(34-2)20(12-17)36-25(26)27/h5-10,12-14,18,23,25H,4,11,28H2,1-3H3 |
| InChIKey | FQBPAEJZBPNQTM-UHFFFAOYSA-N |
| XLogP | 3.31 |
| TPSA | 120.52 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 503.50 |
| LogP ≤ 5 | 3.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Analyze methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate?
The IUPAC name of methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate (CID 174367386) is methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate.
What is the SMILES notation for methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate?
The canonical SMILES for methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate is CCC1CC(C=O)N(C(N)c2ccc(C(=O)C(=O)OC)cc2)N=C1c1ccc(OC)c(OC(F)F)c1.
What is the InChIKey of methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate?
The InChIKey is FQBPAEJZBPNQTM-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H27F2N3O6/c1-4-14-11-18(13-31)30(23(28)16-7-5-15(6-8-16)22(32)24(33)35-3)29-21(14)17-9-10-19(34-2)20(12-17)36-25(26)27/h5-10,12-14,18,23,25H,4,11,28H2,1-3H3.
What are the key properties of methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate?
methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate has a molecular weight of 503.50 g/mol, XLogP of 3.31, 10 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 2-[4-[amino-[6-[3-(difluoromethoxy)-4-methoxyphenyl]-5-ethyl-3-formyl-4,5-dihydro-3H-pyridazin-2-yl]methyl]phenyl]-2-oxoacetate is sourced from PubChem (CID 174367386), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).